Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Propel Biosciences provides outsourced sales and business development services to accelerate commercial success for companies in the cell and gene therapy space. They leverage deep industry expertise to bridge the gap between scientific innovation and market adoption.
The company works with tools, technology, and service providers across the cell and gene therapy ecosystem but does not have its own therapeutic or diagnostic products.
CEO Susan Nichols has extensive experience leading commercialization efforts at major life science organizations.
No clinical results or drug programs are associated with this entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Propel Biosciences.